ロータスは研究開発に力を入れており、製造が難しいとされるジェネリック医薬品を製造しています。 また、世界のさまざまな国でパイプラインを有しており、アメリカ、アジア太平洋、中国などでも製品が上市されています。
最終更新:2017年9月
Compound | Therapeutic Area | Timeline | Regional Scope |
---|---|---|---|
Acarbose | Antidiabetic | 2011 Submission | China |
AK-R214 (SR) | Smoking Cessation | 2017 Clinical Trial | Korea |
AK-R216 | Diabetes | 2019 BE Study | Korea |
AK-R217 | Diabetes | 2019 BE Study | Korea |
AK-R309 | OAB | 2019 BE Study | Korea |
Budesonide ER | GI | 2015 Submission, Sued | US |
Buprenorphine/Naloxone | Anti-Addiction | 2015 Submission, Sued | US |
Divalproex sodium | Anti-Epilepsy | 2008 Submission | China |
Gefitinib | Oncology | 2017 BE Study | US |
Lenalidomide | Oncology | 2017 Submission | Global |
Levetiracetam | Anti-Epilepsy | 2012 Submission | China |
Levonorgestrel | Women Health | 2010 Submission | China |
LP 149 | Women Health | 2018 Submission | Global |
LP 173 | Oncology | 2018 BE Study | EU,APAC |
LP 337 | Oncology | 2019 Submission | EU,APAC |
LP 650 | Oncology | 2017 Formulation | EU,APAC |
Memantine | Anti-Dementia | 2013 Submission | China |
Methotrexate | Oncology | 2019 Launch | US |
Temozolomide | Oncology | 2013 Submission | China |
Vinorelbine softgel capsule | Oncology | 2017 Submission | EU |